Oxford/AstraZeneca coronavirus vaccine approved for use in UK

Published



The United Kingdom approved the use of a coronavirus vaccine developed by Oxford University and AstraZeneca on Wednesday, with the first doses set to be administered next week.

The U.K. has ordered 100 million doses from AstraZeneca, and when combining the number of doses from this vaccine, the Moderna vaccine, and the Pfizer-BioNTech vaccine, the entire population should be able to get vaccinated, Health Secretary Matt Hancock said, according to the BBC.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.